Abivax (AAVXF) Tax Rate (2025 - 2026)
Abivax (AAVXF) posted Tax Rate of 0.47% for Q1 2026, down 93.85% on a QoQ basis from 7.68% in Q4 2025.
Powered by 
Analysis
Abivax (AAVXF) Tax Rate (2025 - 2026) Analysis & Trends
Abivax has reported Tax Rate for 2 years, with the latest figure at 0.47% in Q1 2026.
- On a quarterly basis, Tax Rate changed N/A year-over-year to 0.47% in Q1 2026; TTM through Mar 2026 was 1.87%, a N/A change from a year earlier, with the FY2025 full-year figure at 1.77%, changed N/A from the prior year.
- Tax Rate was 0.47% for Q1 2026 at Abivax, down from 7.68% in the prior quarter.
- The five-year high for Tax Rate was 7.68% in Q4 2025, with the low at 0.47% in Q1 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 212.35 Bn | 198.36 Bn | 7.24 Bn | 14.20% |
| 2 | Gilead Sciences | 181.19 Bn | 178.01 Bn | 6.22 Bn | -2.36% |
| 3 | Vertex Pharmaceuticals | 132.48 Bn | 124.62 Bn | 2.84 Bn | 20.98% |
| 4 | Regeneron Pharmaceuticals | 82.59 Bn | 74.60 Bn | 3.93 Bn | 15.11% |
| 5 | Argenx Se | 61.45 Bn | 56.27 Bn | 1.37 Bn | -10.89% |
| 6 | Moderna | 54.89 Bn | 49.75 Bn | 52.00 Mn | -1.96% |
| 7 | Alnylam Pharmaceuticals | 34.21 Bn | 30.90 Bn | 992.69 Mn | 7.49% |
| 8 | Biogen | 31.38 Bn | 30.10 Bn | 1.96 Bn | 26.36% |
| 9 | Roivant Sciences | 29.81 Bn | 29.81 Bn | 1.16 Mn | 1.34% |
| 10 | Abivax | 10.92 Bn | 10.92 Bn | - | 0.47% |